Osteoporos Int. 2016 Mar;27(3):849-52. doi: 10.1007/s00198-015-3453-y. Epub 2015 Dec 14. No abstract available.
Clinicians need to rethink the assumption that a patient who has taken an oral bisphosphonate for 5 years or an intravenous therapy for 3 years should automatically start a drug holiday. The clinician should individualize the decision for each patient based on their fracture risk.
Autor: Silverman SL, Adachi JD, Dennison E; International Osteoporosis Foundation Epidemiology/Quality of Life Working Group